NOV 14, 2019 12:00 PM PST

Panel Discussion: Emerging technologies in laboratory medicine, opportunities and challenges

Speakers
  • Corresponding member of IFCC C-MHBLM, North Sector POCT Medical Lead, Alberta Public Laboratories, Associate Clinical Professor of Laboratory Medicine, University of Alberta
    Biography
      Anna Füzéry obtained her PhD in biochemistry from the University of Wisconsin-Madison, and subsequently completed a 2-year postdoctoral training program in clinical chemistry at Johns Hopkins Medical Institutes in Baltimore, MD. She accepted a position as clinical chemist for Alberta Health Services in 2013, where she oversaw high volume general chemistry testing at 11 laboratories in Edmonton, Alberta. She became medical lead of point-of-care testing (POCT) for Edmonton in 2017, and for the northern half of the province of Alberta in 2019. Her current interest is in enabling high quality, clinically relevant POCT in mobile health environments.
    • Professor, Head of the Department of Clinical Biochemistry, Cliniques Universitaires Saint Luc
      Biography
        Professor Damien Gruson was awarded his degree of Pharmacist and later of Specialist in Laboratory Medicine from the Catholic University of Louvain, Brussels, Belgium. He is the head of the department of Clinical Biochemistry of the Cliniques Universitaires Saint Luc. He is also member of the research unit on Endocrinology Diabetes and Nutrition of the Catholic University of Louvain. Pr. D. Gruson has published numerous articles in several international peer-reviewed journals. Pr. D. Gruson is member of the division on Emerging Technology of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Pr. D. Gruson is also Fellow of the European Society of Cardiology.

      Abstract:

      Part 1: Sustainable health and laboratory medicine; Presented by Professor Damien Gruson

      Summary: Chronic diseases such as diabetes, cardiovascular diseases, renal failure orcancer are associated with high morbidity and mortality and contribute to a very important part of health expenditure. The prevalence of chronic diseases is increasing also because an aging population. The optimization of the diagnosis and monitoring of patients with chronic diseases is a major challenge in an era of healthcare workforces shortage and budget limitations.

      Emerging technologies are shifting the paradigm of the management of chronic diseases and of the interactions within the healthcare ecosystem. The testing loop process is also transforming with more capacity of remote monitoring. The evolutions of the pre-analytical phase consider now the citizen and patient literacy as well as their empowerment in disease prevention and monitoring. Measurements are shifting because of new generation of sensors and point of care systems.  The role of specialists in laboratory medicine now also includes the validation of these novel technologies, the education of the caregivers and the management of data as the volume of data generated is exponentially increasing. Emerging technologies represent also additional supports for integrated care pathways and multidisciplinary interactions.

      Part 2: Let’s talk about errors in point of care testing in mobile health environments; Presented by Dr. Anna Fuezery

      Summary: The presentation will first review our current understanding of errors in point of care testing (POCT), with a particular emphasis on mobile health environments. The presentation will then discuss general approaches to POCT error quantification, monitoring, and mitigation, as well as the relevance of such approaches to mobile health environments. 

       


      Show Resources
      You May Also Like
      SEP 05, 2019 04:00 PM CEST
      C.E. CREDITS
      SEP 05, 2019 04:00 PM CEST
      DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
      OCT 02, 2019 11:00 AM PDT
      OCT 02, 2019 11:00 AM PDT
      DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
      AUG 27, 2019 09:00 AM PDT
      C.E. CREDITS
      AUG 27, 2019 09:00 AM PDT
      DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
      JUL 30, 2019 10:00 AM PDT
      C.E. CREDITS
      JUL 30, 2019 10:00 AM PDT
      DATE: July 30, 2019TIME: 10:00am PT/ 1:00pm ET The importance of building a validation structure within your lab cannot be overstated. Once in place, the ability to identify high...
      DEC 10, 2019 09:00 AM PST
      C.E. CREDITS
      DEC 10, 2019 09:00 AM PST
      DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
      JUN 26, 2019 09:00 AM PDT
      C.E. CREDITS
      JUN 26, 2019 09:00 AM PDT
      DATE: June 26, 2019TIME: 9:00am PDT, 12:00pm EDT An excessive number of software solutions are available to help manage your clinical, biobank, or biorepository sample inform...
      Loading Comments...
      Show Resources